Back to Walleye Trading LLC Walleye Trading LLC

PTGXPTGX

Showing 0 of 3 quarters

Position history for Walleye Trading LLCWalleye Trading LLC's holdings in PROTAGONIST THERAPEUTICS INC

No. Walleye Trading exited its PTGX (Protagonist Therapeutics) position in Q2 2023. Its Q1 2023 13F listed 105,360 shares worth $2.4M. Walleye Trading first reported PTGX in Q4 2022 and held it in 2 quarterly 13F filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used